Pregnancy Complications
Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases.
Subtype terms (27)
More specific conditions that are subtypes of Pregnancy Complications in the MeSH hierarchy.
- Abortion, Spontaneous
36 drugs (28 approved, 8 experimental)
- Abortion, Threatened
4 drugs (3 approved, 1 experimental)
- Chorea Gravidarum
1 drug experimental
- Diabetes, Gestational
46 drugs (24 approved, 22 experimental)
- Fetal Death
4 drugs approved
- Fetal Diseases
- Hypertension, Pregnancy-Induced
32 drugs (27 approved, 5 experimental)
- Morning Sickness
3 drugs (2 approved, 1 experimental)
- Nuchal Cord
- Obstetric Labor Complications
21 drugs (19 approved, 2 experimental)
- Oligohydramnios
7 drugs (6 approved, 1 experimental)
- Pelvic Floor Disorders
17 drugs (11 approved, 6 experimental)
- Pemphigoid Gestationis
1 drug experimental
- Perinatal Death
15 drugs (11 approved, 4 experimental)
- Phenylketonuria, Maternal
- Placenta Diseases
1 drug approved
- Polyhydramnios
- Pregnancy Complications, Cardiovascular
- Pregnancy Complications, Hematologic
2 drugs approved
- Pregnancy Complications, Infectious
5 drugs (4 approved, 1 experimental)
- Pregnancy Complications, Neoplastic
- Pregnancy, Ectopic
13 drugs (12 approved, 1 experimental)
- Pregnancy in Diabetics
10 drugs approved
- Pregnancy in Obesity
6 drugs (2 approved, 4 experimental)
- Pregnancy, Prolonged
6 drugs (4 approved, 2 experimental)
- Prenatal Injuries
- Puerperal Disorders
8 drugs (7 approved, 1 experimental)
Drugs by status
Phase 4 trials (89)
- metformin
- hydrocodone
- metronidazole
- ferric derisomaltose
- hydroxyprogesterone
- heparin
- iron
- mifepristone
- albendazole
- norgestrel
- follitropin alfa
- aluminum
- oxytocin
- bovine lactoferrin
- carbetocin
- capsaicin
- cefazolin
- alpha-lipoic acid
- ibuprofen
- progesterone
- betamethasone
- dydrogesterone
- egg
- ferrous fumarate
- ferric carboxymaltose
- ferric sulfate
- ferrous glycine sulphate complex
- folic acid
- fumaric acid esters
- ethinyl estradiol
- +59 more
Phase 3 trials (50)
- nitrous oxide
- melatonin
- efavirenz
- vitamin d3
- calcium carbonate
- arabin pessary
- beta carotene
- oxycodone
- copper
- prednisone
- nifedipine
- doxylamine
- enalapril
- leuprolide
- naltrexone
- dolutegravir
- hydroxychloroquine
- calcium
- insulin human
- warfarin
- artesunate
- drospirenone
- ursodeoxycholic acid
- phenindione
- mefloquine
- sitagliptin
- levobupivacaine
- buprenorphine
- sulfamethoxazole
- clonidine
- +20 more
Phase 2 trials (25)
Phase 1 trials (12)
Other trials (64)
- phenylephrine
- maltodextrin
- nitroglycerin
- procaine benzylpenicillin
- cefoxitin
- norepinephrine
- ketamine
- clavulanate
- cranberry
- daclizumab
- dimethyl fumarate
- vitis vinifera
- gabapentin
- ganirelix
- tenofovir
- epidermal growth factor
- terbutaline
- ephedrine
- iron sucrose
- magnesium lactate
- myoinositol
- orange juice
- human milk
- evolocumab
- cow milk
- Atosiban
- potassium chloride
- saccharin
- atropine
- coffee
- +34 more
Organizations
Organization Involved with Phase 4 Indications (19)
- Vifor Inc.
- Malaria Consortium
- Malaria Consortium, UK
- Ain Shams University
- Cairo University
- University of London
- Mahidol University
- Tanta University
- University of Oslo
- Istanbul University
- Southeast University
- University of Lille
- University of Nigeria
- University of Massachusetts
- University of Paris
- Poissy Hospital
- French Health Products Safety Agency
- Government of France
- Oslo Metropolitan University
Organization Involved with Phase 3 Indications (30)
- Duchesnay Inc.
- Fetal Medicine Foundation
- National Institutes of Health (NIH)
- World Health Organization
- Centre Hospitalier Intercommunal Creteil
- Harvard University
- Hahnemann University Hospital
- Hawaii Pacific Health
- McMaster University
- Stanford University
- University of Ottawa
- University of Toronto
- University of Adelaide
- University of Bologna
- Epsom and St Helier University Hospitals NHS Trust
- University of Copenhagen
- University of Vienna
- American University of Beirut
- Karolinska Institute
- Osakidetza
- Premier Research Group
- University of Barcelona
- University of North Carolina at Chapel Hill
- Universidad Autonoma de Barcelona
- Muhimbili University
- Moorgreen Hospital, Southampton
- George Washington University
- Canadian Institutes of Health Research (CIHR)
- Medway NHS Foundation Trust
- The University of Texas, Dallas
Organization Involved with Phase 2 Indications (5)
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (19)
- Al Hayat National Hospital
- Chang Gung University
- Ibn Sina Hospital
- Menoufia University
- Postgraduate Institute of Medical Education and Research
- University of Tehran
- University of Calgary
- Icahn School of Medicine at Mount Sinai
- Emek Medical Center
- Maccabi Healthcare Services, Israel
- University of Texas at Houston
- University of Gothenburg
- Assuta Ashdod Hospital
- Heilongjiang University of Traditional Chinese Medicine
- Hegang maternal and child health care hospital
- Harbin maternal and child health care hospital
- Jixi maternal and child health care hospital
- Jiamusi maternal and child health care hospital
- Mudanjiang maternal and child health care hospital